Correlation Between KABE Group and Clinical Laserthermia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both KABE Group and Clinical Laserthermia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining KABE Group and Clinical Laserthermia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between KABE Group AB and Clinical Laserthermia Systems, you can compare the effects of market volatilities on KABE Group and Clinical Laserthermia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in KABE Group with a short position of Clinical Laserthermia. Check out your portfolio center. Please also check ongoing floating volatility patterns of KABE Group and Clinical Laserthermia.

Diversification Opportunities for KABE Group and Clinical Laserthermia

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between KABE and Clinical is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding KABE Group AB and Clinical Laserthermia Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clinical Laserthermia and KABE Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on KABE Group AB are associated (or correlated) with Clinical Laserthermia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clinical Laserthermia has no effect on the direction of KABE Group i.e., KABE Group and Clinical Laserthermia go up and down completely randomly.

Pair Corralation between KABE Group and Clinical Laserthermia

Assuming the 90 days trading horizon KABE Group AB is expected to generate 0.33 times more return on investment than Clinical Laserthermia. However, KABE Group AB is 3.01 times less risky than Clinical Laserthermia. It trades about -0.04 of its potential returns per unit of risk. Clinical Laserthermia Systems is currently generating about -0.14 per unit of risk. If you would invest  30,710  in KABE Group AB on August 24, 2024 and sell it today you would lose (810.00) from holding KABE Group AB or give up 2.64% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

KABE Group AB  vs.  Clinical Laserthermia Systems

 Performance 
       Timeline  
KABE Group AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days KABE Group AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's fundamental drivers remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Clinical Laserthermia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Clinical Laserthermia Systems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

KABE Group and Clinical Laserthermia Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with KABE Group and Clinical Laserthermia

The main advantage of trading using opposite KABE Group and Clinical Laserthermia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if KABE Group position performs unexpectedly, Clinical Laserthermia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clinical Laserthermia will offset losses from the drop in Clinical Laserthermia's long position.
The idea behind KABE Group AB and Clinical Laserthermia Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope